StonvexLoading…
StonvexStonvexStonvexCore line items from BBY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-02-01 | Annual 2024 2024-02-03 | Annual 2023 2023-01-28 |
|---|---|---|---|---|
Revenue | $41.69B | $41.53B | $43.45B | $46.30B |
Operating Income | $1.39B | $1.26B | $1.57B | $1.79B |
Net Income | $1.07B | $927.00M | $1.24B | $1.42B |
EPS (Diluted) | $5.04 | $4.28 | $5.68 | $6.29 |
Total Assets | $14.67B | $14.78B | $14.97B | $15.80B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.74B | $1.58B | $1.45B | $1.87B |
Free Cash Flow OCF − CapEx | $1.26B | $1.39B | $675.00M | $894.00M |
Shares Outstanding | 209.10M | 211.40M | 215.40M | 218.10M |